[Susceptibility of pathogens isolated from clinical specimens to lividomycin].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002228:Carbenicillin / Q000494:pharmacology; D002509:Cephaloridine / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D006190:Haemophilus / Q000187:drug effects; D007612:Kanamycin / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D002228:Carbenicillin; D002509:Cephaloridine; D003091:Colistin